PRISM Pharma Publication: Atea (AVIR) Publishes Additional Data on Bemnifosbuvir

PRISM Pharma Index company Atea Pharmaceuticals, Inc. (AVIR), a clinical-stage biopharmaceutical company focused on developing oral antiviral treatments for serious viral diseases, announced today the publication of data on the metabolic activation pathway of bemnifosbuvir in the peer-reviewed journal PLOS Biology. The article, titled “The activation cascade of the broad-spectrum antiviral bemnifosbuvir characterized at atomic… [Read More]

SoundHound AI’s (SOUN) Amelia Acquisition Introduces Emily, MUSC Health’s New AI Agent Powered by Amelia Patient Engagement

Earlier this month, SoundHound AI (SOUN) announced the acquisition of Amelia AI which allowed the company to widen its scope and ability to service multiple industries that include retail, financial services, healthcare automotive and smart devices. Today the company announced its first partnership enabled by Amelia, with Charleston-based, MUSC Health to transform patient access with… [Read More]

Costco (COST) Gains While Market Falls: Market Facts

The most recent market close witnessed Costco (COST) positioned at an impressive $892.51, marking a positive change of +1.51% from the prior day’s ending trading session. Interestingly, this performance surpassed the S&P 500’s daily drop of 0.32%, even as the Dow increased by 0.16% and the tech-rich Nasdaq fell by 0.85%. In the past month,… [Read More]

Pickleball Just Became the Real Dill as Trulieve (TCNNF) Announces Partnership with Two Major Pickleball Associations

Trulieve Cannabis Corp. (TCNNF) a leading cannabis company in the U.S., today announced a partnership with the Carvana PPA Tour (“PPA Tour”) and MLP by Margaritaville (“MLP”) to sponsor premier pickleball events in Arizona, Florida, and Georgia. The Professional Pickleball Association (PPA) Tour is the world’s largest professional and amateur pickleball tour, with 25 tour… [Read More]

PRISM Biotech Index Leader Addex (ADXN) Sees Shares Rise on Selection of Candidates from GABAB Positive Allosteric Modulator Research Collaboration

PRISM Biotech Index leader and clinical-stage biopharmaceutical company dedicated to developing a portfolio of novel small molecule allosteric modulators for neurological disorders, Addex Therapeutics (ADXN) announced today, alongside Indivior PLC (INDV) the selection of clinical candidates from their GABAB positive allosteric modulator (PAM) research collaboration. Indivior has chosen a compound for future development in the… [Read More]

Stocks making the biggest moves premarket: Paramount Global, Cava, JD.com and more

Catch up on the corporate headlines that are drawing everyone’s attention during pre-market trading. Paramount Global, the media giant, saw its shares tumble almost 5% following Edgar Bronfman Jr.’s retraction of his bid for the company. This development paves the way for Skydance Media to acquire Shari Redstone’s media realm. Paramount envisions finalizing the Skydance… [Read More]

Sparks Fly: Fire Damages Rivian (RIVN) EVs at Illinois Plant

A fire broke out late Saturday night in the parking lot of Rivian Automotive’s (Nasdaq: RIVN) manufacturing facility in Normal, Illinois, damaging several of the company’s electric vehicles. The incident occurred around 9:45 p.m., prompting a response from local fire departments. Fortunately, no injuries were reported, and the assembly plant itself was unaffected. The fire… [Read More]

SciSparc Submits Application to FDA to Advance Tourette Syndrome Phase 2b Clinical Trial

SciSparc Ltd. (Nasdaq: SPRC), a clinical-stage pharmaceutical company specializing in treatments for central nervous system disorders and rare diseases, has submitted an Investigational New Drug (IND) application with the FDA for a Phase 2b clinical trial of SCI-110, aimed at treating Tourette Syndrome (TS). TS is a neurological disorder that affects about 1.4 million people… [Read More]

Peloton (PTON) Narrowing Losses and Focusing on Profitability as Sales Inch Up

Peloton (Nasdaq: PTON) announced Thursday that it is making progress toward profitability, reporting a slight sales increase for the first time in nine quarters while significantly reducing its overall losses. Shares of Peloton surged 35% following the news. The company, under interim co-CEOs, saw a modest 0.2% growth in sales during its fiscal fourth quarter,… [Read More]